Sorafenib Inhibits the Imatinib-Resistant KIT T670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies2006 · 470 citations
2. 2Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor2004 · 1,809 citations
3. 3BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis2004 · 4,057 citations
4. 4Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors2006 · 822 citations
5. 5Heat Shock Protein 90 Inhibition in Imatinib-Resistant Gastrointestinal Stromal Tumor2006 · 265 citations